These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28603011)

  • 1. A comprehensive spectroscopic study of the polymorphs of diflunisal and their phase transformations.
    Pallipurath AR; Civati F; Sibik J; Crowley C; Zeitler JA; McArdle P; Erxleben A
    Int J Pharm; 2017 Aug; 528(1-2):312-321. PubMed ID: 28603011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interrelation between thermochemical and structural data of polymorphs exemplified by diflunisal.
    Perlovich GL; Hansen LK; Bauer-Brandl A
    J Pharm Sci; 2002 Apr; 91(4):1036-45. PubMed ID: 11948542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A thermodynamic based approach on the investigation of a diflunisal pharmaceutical co-crystal with improved intrinsic dissolution rate.
    Evora AO; Castro RA; Maria TM; Silva MR; Ter Horst JH; Canotilho J; Eusébio ME
    Int J Pharm; 2014 May; 466(1-2):68-75. PubMed ID: 24607201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism of diflunisal: isolation and solid-state characteristics of a new crystal form.
    Martínez-Ohárriz MC; Martín C; Goñi MM; Rodríguez-Espinosa C; Tros de Ilarduya-Apaolaza MC; Sánchez M
    J Pharm Sci; 1994 Feb; 83(2):174-7. PubMed ID: 8169784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid phase drug-drug pharmaceutical co-crystal formed between pyrazinamide and diflunisal: Structural characterization based on terahertz/Raman spectroscopy combining with DFT calculation.
    Wu X; Wang Y; Xue J; Liu J; Qin J; Hong Z; Du Y
    Spectrochim Acta A Mol Biomol Spectrosc; 2020 Jun; 234():118265. PubMed ID: 32203686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermodynamic Stability Analysis of Tolbutamide Polymorphs and Solubility in Organic Solvents.
    Svärd M; Valavi M; Khamar D; Kuhs M; Rasmuson ÅC
    J Pharm Sci; 2016 Jun; 105(6):1901-1906. PubMed ID: 27238487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of polymorphic ampicillin forms.
    Baraldi C; Tinti A; Ottani S; Gamberini MC
    J Pharm Biomed Anal; 2014 Nov; 100():329-340. PubMed ID: 25194347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of polyethylene glycol 4000 on the polymorphic forms of diflunisal.
    Martínez-Ohárriz MC; Martín C; Goñi MM; Rodríguez-Espinosa C; Tros-Ilarduya MC; Zornoza A
    Eur J Pharm Sci; 1999 May; 8(2):127-32. PubMed ID: 10210735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of amorphous states prepared by melt-quenching and cryomilling polymorphs of carbamazepine.
    Guinet Y; Paccou L; Danède F; Willart JF; Derollez P; Hédoux A
    Int J Pharm; 2016 Jul; 509(1-2):305-313. PubMed ID: 27237427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal forms of naproxen.
    Song JS; Sohn YT
    Arch Pharm Res; 2011 Jan; 34(1):87-90. PubMed ID: 21468919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ball-milling and cryomilling on sulfamerazine polymorphs: a quantitative study.
    Macfhionnghaile P; Hu Y; Gniado K; Curran S; Mcardle P; Erxleben A
    J Pharm Sci; 2014 Jun; 103(6):1766-78. PubMed ID: 24756899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermodynamic Investigation of Carbamazepine-Saccharin Co-Crystal Polymorphs.
    Pagire SK; Jadav N; Vangala VR; Whiteside B; Paradkar A
    J Pharm Sci; 2017 Aug; 106(8):2009-2014. PubMed ID: 28435141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystallization and transitions of sulfamerazine polymorphs.
    Zhang GG; Gu C; Zell MT; Burkhardt RT; Munson EJ; Grant DJ
    J Pharm Sci; 2002 Apr; 91(4):1089-100. PubMed ID: 11948548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid-state fluorescence studies of some polymorphs of diflunisal*.
    Brittain HG; Elder BJ; Isbester PK; Salerno AH
    Pharm Res; 2005 Jun; 22(6):999-1006. PubMed ID: 15948044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermodynamics of the Enantiotropic Pharmaceutical Compound Benzocaine and Solubility in Pure Organic Solvents.
    Cheuk D; Svärd M; Rasmuson ÅC
    J Pharm Sci; 2020 Nov; 109(11):3370-3377. PubMed ID: 32777220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the drug-polymer interaction in calcium alginate beads containing diflunisal.
    Mandal B; Alexander KS; Riga AT
    Pharmazie; 2010 Feb; 65(2):106-9. PubMed ID: 20225653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raman detected differential scanning calorimetry of polymorphic transformations in acetaminophen.
    Kauffman JF; Batykefer LM; Tuschel DD
    J Pharm Biomed Anal; 2008 Dec; 48(5):1310-5. PubMed ID: 18930622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissolution kinetics for coprecipitates of diflunisal with PVP K30.
    Rodríguez-Espinosa C; Martínez-Ohárriz MC; Martín C; Goñi MM; Vélaz I; Sánchez M
    Eur J Drug Metab Pharmacokinet; 1998; 23(2):109-12. PubMed ID: 9725466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermal, spectroscopic, and ab initio structural characterization of carprofen polymorphs.
    Bruni G; Gozzo F; Capsoni D; Bini M; Macchi P; Simoncic P; Berbenni V; Milanese C; Girella A; Ferrari S; Marini A
    J Pharm Sci; 2011 Jun; 100(6):2321-32. PubMed ID: 21246561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase transformation in conformational polymorphs of nimesulide.
    Sanphui P; Sarma B; Nangia A
    J Pharm Sci; 2011 Jun; 100(6):2287-99. PubMed ID: 21491446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.